Written by Klarity Editorial Team
Published: Aug 19, 2026

Last updated: August 19, 2026
Buspirone (the generic for the discontinued brand BuSpar) is a non-benzodiazepine anxiety medicine. It is not a rescue pill. You take it on a schedule, usually twice a day, and it often takes several weeks to show a clear effect. This guide covers how buspirone works, typical tablet strengths and titration, food and grapefruit rules, MAOI and CYP3A4 interactions, and when a video visit is enough to review it.
Want a licensed clinician to review anxiety treatment options, including whether buspirone may fit?
See online anxiety treatment options · Browse conditions
According to MedlinePlus, buspirone treats anxiety. It changes the amounts of certain natural substances in the brain. The brand name BuSpar is marked discontinued; generic tablets remain on the market.
NAMI places buspirone in its own anti-anxiety class. It is not related to benzodiazepines, barbiturates, or other sedative anxiolytics. Approval is for GAD: excessive worry for at least six months plus restlessness, fatigue, trouble concentrating, irritability, muscle tension, or sleep disturbance.
DailyMed labels buspirone hydrochloride as an antianxiety agent that is not chemically or pharmacologically related to benzodiazepines. Indication: management of anxiety disorders or short-term relief of anxiety symptoms. Everyday stress usually does not need an anxiolytic. Efficacy was shown in outpatient trials that roughly match GAD; many patients also had depressive symptoms, and buspirone still reduced anxiety. Controlled data do not establish use beyond 3 to 4 weeks, though one long-term study treated 264 patients for a year without ill effect. Clinicians who continue it should reassess usefulness over time.
NAMI notes very low abuse potential and no cross-tolerance with other sedative anxiolytics. That is why many people ask about buspirone when they want an option that is not a benzo and is not a controlled substance.
MedlinePlus: tablets by mouth, twice daily, always with food or always without food. Split scored tablets at the groove if your clinician asks for a partial tablet. Start low and raise the dose no more often than every 2 to 3 days. It may take several weeks to reach a dose that works.
NAMI: twice a day, with or without food, stay consistent. It is for continuous use, not as-needed spikes. Do not stop without talking with your clinician first.
DailyMed food note: in eight subjects, a 20 mg dose with food raised AUC 84% and Cmax 116% for unchanged buspirone, while total immunoreactive material did not change. Food may reduce first-pass clearance. That is why the label wants a consistent food pattern, not random switching.
Missed dose (MedlinePlus and NAMI): take it when you remember unless it is almost time for the next dose. Do not double up.
Storage (MedlinePlus): original container, room temperature, away from light, heat, and bathroom moisture. Do not flush leftovers. Use a take-back program. Overdose: poison control 1-800-222-1222 or poisonhelp.org. Overdose symptoms can include nausea, vomiting, dizziness, drowsiness, and blurred vision.
NAMI tablet strengths: 5 mg, 7.5 mg, 10 mg, 15 mg, 30 mg. DailyMed also describes scored 5 mg and 10 mg tablets (halves) and a 15 mg tablet that can be bisected or trisected into 15, 10, 7.5, or 5 mg pieces.
DailyMed adult titration:
Pediatric note from DailyMed: two 6-week placebo-controlled GAD trials in 559 patients ages 6 to 17 used 7.5-30 mg twice daily (15-60 mg/day). Buspirone did not separate from placebo on GAD symptoms. Plasma exposure was equal to or higher than in adults. There are no long-term pediatric safety or efficacy data. Do not treat this as a pediatric how-to.
Your clinician sets the schedule. This page is education, not a dose calculator.
Check if an online anxiety visit may fit
NAMI: no boxed warning. Common effects include nausea, headache, dream changes, dizziness, drowsiness, or lightheadedness. Rare or serious: weight or appetite change, fainting, blood-pressure change, muscle cramps, red or itchy eyes, allergic swelling, chest pain or irregular heartbeat, slurred speech, confusion, numbness or tingling, or uncontrollable movements. Do not drive until you know how you react. Alcohol can add drowsiness. Breastfeeding: caution; it is unknown whether buspirone passes into milk. NAMI reports no known problems with long-term use when directed.
MedlinePlus common effects: dizziness; nausea or diarrhea; headache; excitement; confusion; fatigue; nervousness; insomnia; anger or hostility; lightheadedness; weakness; numbness. Call promptly for rash, hives, facial swelling, fast or irregular heartbeat, blurred vision, tremor, or serotonin-syndrome-type clusters (agitation, fever, sweating, stiffness, twitching, seizures, hallucinations).
Tell your clinician about kidney or liver disease, alcohol or drug history, pregnancy plans, and any upcoming surgery, including dental work. Report buspirone before lab tests.
If you have thoughts of suicide or self-harm, call or text 988 (Suicide & Crisis Lifeline) or go to the nearest emergency department.
MAOIs. MedlinePlus: do not take buspirone if you use or recently stopped (within two weeks) an MAOI such as isocarboxazid, linezolid, methylene blue, phenelzine, selegiline, or tranylcypromine. DailyMed and NAMI: combining with an MAOI has been tied to elevated blood pressure. DailyMed also says buspirone has no established antipsychotic activity and should not replace antipsychotic treatment.
Grapefruit and CYP3A4. DailyMed: metabolism is mainly CYP3A4. Grapefruit juice (200 mL double-strength three times daily for 2 days with a 10 mg dose) raised Cmax 4.3-fold and AUC 9.2-fold. Avoid large amounts of grapefruit juice. Verapamil raised AUC and Cmax about 3.4-fold; diltiazem raised AUC 5.3-fold and Cmax 4-fold. Potent inhibitors (ketoconazole, ritonavir) may require a low, cautious buspirone dose. Inducers (dexamethasone, phenytoin, phenobarbital, carbamazepine, rifampin) may require a higher dose to keep the effect. NAMI also lists diltiazem, verapamil, and erythromycin as level-raisers and rifampin and phenytoin as level-cutters. MedlinePlus flags nonprescription cimetidine as a possible interactor.
Bring a full list of prescriptions, OTC products, and supplements to every visit.
Buspirone is not a controlled substance on the DailyMed label (DEA Schedule: None). That usually makes remote prescribing simpler than benzodiazepines. A licensed clinician still needs a history: GAD symptoms, prior meds, MAOI washout, liver or kidney disease, pregnancy, alcohol use, and a current med list. Follow-up is often a good fit for video because titration is slow and the medicine is not a rescue dose.
Telehealth is usually not enough if you have chest pain, fainting, severe allergic swelling, seizures, or a possible serotonin-syndrome picture. Those need urgent in-person care.
Per HHS telehealth policy updates (February 5, 2026): Medicare patients can permanently receive behavioral and mental health telehealth in the home, with no geographic originating-site restriction, including audio-only when that is appropriate. The extra in-person visit that would otherwise be required within six months of an initial behavioral telehealth service, and yearly after that, is waived through December 31, 2027. Commercial and Medicaid rules still vary by plan and state.
Klarity Health works with 2,000+ licensed providers. Coverage for visits and prescriptions may vary by plan. Verify benefits before you book. This article is educational and is not a diagnosis, a prescription, or a coverage promise.
See if you may qualify for online anxiety care · Explore conditions
BuSpar was the brand. MedlinePlus lists it as discontinued. Generic buspirone tablets are what most pharmacies dispense.
NAMI: 3 to 4 weeks of daily use. Early changes, if they come, are often less irritability and less worry. It is not a same-day calm pill.
NAMI says no. It is meant for continuous use, not as-needed rescue.
Many plans place generic buspirone on a lower pharmacy tier, but coverage, prior authorization, and copays vary. Confirm with your plan and PBM. Do not assume coverage from this page.
Often yes, if a licensed clinician decides it is appropriate after a visit. It is not a controlled substance on the DailyMed label. Klarity can connect you with 2,000+ licensed providers. Eligibility and prescribing still depend on your history, state rules, and clinical judgment.
Disclaimer: Coverage and prescribing vary by plan, state, and clinical findings. Verify benefits before you book. This content is not medical advice. If you are in crisis, call or text 988.
Find the right provider for your needs — select your state to find expert care near you.